Comparing the technical reliability and insulin dosing of a "do‐it‐yourself artificial pancreas" with a commercial hybrid closed‐loop system in a "shadow‐mode" scenario: An exploratory study.

Comparing the technical reliability and insulin dosing of a "do-it-yourself artificial pancreas" with a commercial hybrid closed-loop system in a "shadow-mode" scenario: An exploratory study Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study. Keywords: CSII; insulin pump therapy; subcutaneous injection; type 1 diabetes EN CSII insulin pump therapy subcutaneous injection type 1 diabetes 2780 2783 4 08/03/23 20230901 NES 230901 INTRODUCTION Do-it-yourself artificial pancreas systems (DIYAPSs) are compound devices that autonomously adjust insulin dosage in people with diabetes. However, the DIYAPS was not delivering insulin, which might have caused an overcompensation of insulin adaptions if delivered insulin doses were lower than calculated by the DIYAPS. [Extracted from the article]